{"id":"W2884876277","doi":"10.1158/1078-0432.ccr-18-0981","title":"Randomized Phase II Study Evaluating Akt Blockade with Ipatasertib, in Combination with Abiraterone, in Patients with Metastatic Prostate Cancer with and without PTEN Loss","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":310,"is_retracted":false,"has_abstract":true,"ca_institutions":"Institute of Cancer Research","funders":"Genentech; F. Hoffmann-La Roche","keywords":"PTEN; Prostate cancer; Medicine; Abiraterone; Blockade; Oncology; Cancer; Randomized controlled trial; Prostate; Internal medicine; Metastatic breast cancer; PI3K/AKT/mTOR pathway; Breast cancer; Androgen receptor; Biology; Receptor; Apoptosis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low","status":"direct model label, unvalidated"},{"model":"gpt","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high","status":"direct model label, unvalidated"}],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005890006,0.0004009946,0.00139549,0.0005352701,0.0003261533,0.00009962976,0.0002065184,0.00008858144,0.0001329172],"category_scores_gemma":[0.0003346024,0.0002041224,0.00003795171,0.001536088,0.002403261,0.0003178079,0.0001635689,0.001191888,0.000004917354],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004598112,"about_ca_system_score_gemma":0.001841741,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004413332,"about_ca_topic_score_gemma":0.0137302,"domain_scores_codex":[0.9931024,0.001677399,0.0008753008,0.001116578,0.00219539,0.001032894],"domain_scores_gemma":[0.9964599,0.0006186811,0.0002487898,0.0005413256,0.001704026,0.0004272623],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.4399385,0.004276763,0.5450659,0.0001331514,0.0004213426,0.0001118527,0.001872556,0.00001844064,0.00001605074,0.000002015798,0.00001878025,0.008124634],"study_design_scores_gemma":[0.6841337,0.07152005,0.2397518,0.001614806,0.0003513876,0.000004761222,0.0008965958,0.001045402,0.0003340653,0.00002899395,0.00002513496,0.0002932913],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9871895,0.0005568333,0.00001100756,0.001378602,0.00003439306,0.01065854,0.00006117197,0.00003091891,0.00007902663],"genre_scores_gemma":[0.9943894,0.0002860476,0.0003615835,0.00008744035,0.00008244385,0.003950384,0.00008868518,0.00008791478,0.0006661367],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3053141,"threshold_uncertainty_score":0.8854915,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1848900057240528,"score_gpt":0.5496204690412394,"score_spread":0.3647304633171866,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}